Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review.
Cancer
Cognitive function
Ethnicity
Healthcare disparities
Race
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
19
04
2023
accepted:
30
06
2023
medline:
31
8
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
Disparities in cognitive function among racial and ethnic groups have been reported in non-cancer conditions, but cancer-related cognitive impairment (CRCI) in racial and ethnic minority groups is poorly understood. We aimed to synthesize and characterize the available literature about CRCI in racial and ethnic minority populations. We conducted a scoping review in the PubMed, PsycInfo, and Cumulative Index to Nursing and Allied Health Literature databases. Articles were included if they were published in English or Spanish, reported cognitive functioning in adults diagnosed with cancer, and characterized the race or ethnicity of the participants. Literature reviews, commentaries, letters to the editor, and gray literature were excluded. Seventy-four articles met the inclusion criteria, but only 33.8% differentiated the CRCI findings by racial or ethnic subgroups. There were associations between cognitive outcomes and the participants' race or ethnicity. Additionally, some studies found that Black and non-white individuals with cancer were more likely to experience CRCI than their white counterparts. Biological, sociocultural, and instrumentation factors were associated with CRCI differences between racial and ethnic groups. Our findings indicate that racial and ethnic minoritized individuals may be disparately affected by CRCI. Future research should use standardized guidelines for measuring and reporting the self-identified racial and ethnic composition of the sample; differentiate CRCI findings by racial and ethnic subgroups; consider the influence of structural racism in health outcomes; and develop strategies to promote the participation of members of racial and ethnic minority groups.
Identifiants
pubmed: 37432455
doi: 10.1007/s00432-023-05088-0
pii: 10.1007/s00432-023-05088-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
12561-12587Subventions
Organisme : NINR NIH HHS
ID : T32NR019035
Pays : United States
Organisme : NINR NIH HHS
ID : K01NR017903
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA226080
Pays : United States
Organisme : NINR NIH HHS
ID : T32NR019035
Pays : United States
Organisme : NINR NIH HHS
ID : K01NR017903
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA226080
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Albert MA, Durazo EM, Slopen N et al (2017) Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: rationale, design, and baseline characteristics. Am Heart J 192:1–12. https://doi.org/10.1016/j.ahj.2017.06.012
doi: 10.1016/j.ahj.2017.06.012
pubmed: 28938955
pmcid: 5748933
Alhareeri AA, Archer KJ, Fu H et al (2020) Telomere lengths in women treated for breast cancer show associations with chemotherapy, pain symptoms, and cognitive domain measures: a longitudinal study. Breast Cancer Res 22:1–18. https://doi.org/10.1186/s13058-020-01368-6
doi: 10.1186/s13058-020-01368-6
Amidi A, Christensen S, Mehlsen M et al (2015) Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer. Br J Cancer 113:794–801. https://doi.org/10.1038/bjc.2015.243
doi: 10.1038/bjc.2015.243
pubmed: 26171932
pmcid: 4559822
Amidi A, Hosseini SMH, Leemans A et al (2017) Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djx085
doi: 10.1093/jnci/djx085
pubmed: 29617869
Anderson DE, Kedar S, Bhatt VR et al (2020) Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: a feasibility study. J Neurol Sci 410:116644. https://doi.org/10.1016/j.jns.2019.116644
doi: 10.1016/j.jns.2019.116644
pubmed: 31901718
Apple AC, Ryals AJ, Alpert KI et al (2017) Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. NeuroImage Clin 14:685–691. https://doi.org/10.1016/j.nicl.2017.03.004
doi: 10.1016/j.nicl.2017.03.004
pubmed: 28377882
pmcid: 5369871
Areán PA, Gallagher-Thompson D (1996) Issues and recommendations for the recruitment and retention of older ethnic minority adults into clinical research. J Consult Clin Psychol 64:875–880. https://doi.org/10.1037//0022-006x.64.5.875
doi: 10.1037//0022-006x.64.5.875
pubmed: 8916614
Arksey H, O’Malley L (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:19–32. https://doi.org/10.1080/1364557032000119616
doi: 10.1080/1364557032000119616
Barnes LL, Lewis TT, Begeny CT et al (2012) Perceived discrimination and cognition in older African Americans. J Int Neuropsychol Soc 18:856–865. https://doi.org/10.1017/S1355617712000628
doi: 10.1017/S1355617712000628
pubmed: 22595035
pmcid: 3432700
Becker BW, Thames AD, Woo E et al (2011) Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav 15:1888–1894. https://doi.org/10.1007/s10461-011-9924-z
doi: 10.1007/s10461-011-9924-z
pubmed: 21437726
pmcid: 3616486
Beyer KMM, Laud PW, Zhou Y, Nattinger AB (2019) Housing discrimination and racial cancer disparities among the 100 largest US metropolitan areas. Cancer 125:3818–3827. https://doi.org/10.1002/cncr.32358
doi: 10.1002/cncr.32358
pubmed: 31287559
Berger AM, Grem J, Garlinghouse M et al (2023) Neurocognitive function and quality-of-life in patients with colorectal cancer. Eur J Oncol Nurs 64:102304. https://doi.org/10.1016/j.ejon.2023.102304
doi: 10.1016/j.ejon.2023.102304
pubmed: 37137248
Bhopal RS (2007) The concepts of ethnicity and race in health and their implications in the context of international migration. Migration, ethnicity, race, and health in multicultural societies, 2nd edn. Oxford University Press, Oxford
doi: 10.1093/acprof:oso/9780198568179.001.0001
Bonham VL (2023) Race. In: Natl. Hum. Genome Res. Inst. https://www.genome.gov/genetics-glossary/Race . Accessed 9 Jun 2023
Boyd RW, Lindo EG, Weeks LD, McLemore MR (2020) On racism: a new standard for publishing on racial health inequities. In: Health Aff. https://www.healthaffairs.org/do/10.1377/forefront.20200630.939347/ . Accessed 26 Feb 2022
Calvio L, Feuerstein M, Hansen J, Luff GM (2009) Cognitive limitations in occupationally active malignant brain tumour survivors. Occup Med (chic Ill) 59:406–412. https://doi.org/10.1093/occmed/kqp094
doi: 10.1093/occmed/kqp094
Carroll JE, Small BJ, Tometich D et al (2019a) Sleep disturbance and neurocognitive outcomes in older breast cancer patients: Interaction with genotype. Cancer 125:4516–4524. https://doi.org/10.1002/cncr.32489
doi: 10.1002/cncr.32489
pubmed: 31553501
Carroll JE, Van Dyk K, Bower JE et al (2019b) Cognitive performance in breast cancer survivors and markers of biological aging. Cancer 125:298–306. https://doi.org/10.1002/cncr.31777
doi: 10.1002/cncr.31777
pubmed: 30474160
Carroll JE, Nakamura ZM, Small BJ et al (2023) Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the thinking and living with cancer study. J Clin Oncol 41:295–306. https://doi.org/10.1200/JCO.22.00406
doi: 10.1200/JCO.22.00406
pubmed: 36179271
Castora-Binkley M, Peronto CL, Edwards JD, Small BJ (2015) A longitudinal analysis of the influence of race on cognitive performance. J Gerontol Ser B Psychol Sci Soc Sci 70:512–518. https://doi.org/10.1093/geronb/gbt112
doi: 10.1093/geronb/gbt112
Castro-Sales MV, Suemoto CK, Apolinario D et al (2019) Effects of adjuvant chemotherapy on cognitive function of patients with early-stage colorectal cancer. Clin Colorect Cancer 18:19–27. https://doi.org/10.1016/j.clcc.2018.09.002
doi: 10.1016/j.clcc.2018.09.002
Chae JW, Chua PS, Ng T et al (2018) Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study. Breast Cancer Res Treat 168:713–721. https://doi.org/10.1007/s10549-017-4640-7
doi: 10.1007/s10549-017-4640-7
pubmed: 29313215
Chen BT, Ghassaban K, Jin T et al (2018a) Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: a pilot MRI study. Magn Reson Imaging 54:218–224. https://doi.org/10.1016/j.mri.2018.07.016
doi: 10.1016/j.mri.2018.07.016
pubmed: 30076946
pmcid: 6298788
Chen BT, Sethi SK, Jin T et al (2018b) Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study. Breast Cancer Res. https://doi.org/10.1186/s13058-018-0965-3
doi: 10.1186/s13058-018-0965-3
pubmed: 30185216
pmcid: 6125882
Chen BT, Jin T, Patel SK et al (2019) Intrinsic brain activity changes associated with adjuvant chemotherapy in older women with breast cancer: a pilot longitudinal study. Breast Cancer Res Treat 176:181–189. https://doi.org/10.1007/s10549-019-05230-y
doi: 10.1007/s10549-019-05230-y
pubmed: 30989462
pmcid: 6551279
Cheung YT, Shwe M, Tan YP et al (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 23:2547–2552. https://doi.org/10.1093/annonc/mds029
doi: 10.1093/annonc/mds029
pubmed: 22396443
Cheung YT, Lim SR, Ho HK, Chan A (2013) Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS ONE 8:e81234. https://doi.org/10.1371/journal.pone.0081234
doi: 10.1371/journal.pone.0081234
pubmed: 24339912
pmcid: 3855252
Choi H, Schoeni RF, Martin LG, Langa KM (2018) Trends in the prevalence and disparity in cognitive limitations of Americans 55–69 years old. J Gerontol Ser B Psychol Sci Soc Sci 73:S29–S37. https://doi.org/10.1093/geronb/gbx155
doi: 10.1093/geronb/gbx155
Churchwell K, Elkind MSV, Benjamin RM et al (2020) Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association. Circulation 142:e454–e468. https://doi.org/10.1161/CIR.0000000000000936
doi: 10.1161/CIR.0000000000000936
pubmed: 33170755
Cory JM (2021) White privilege in neuropsychology: an “invisible knapsack” in need of unpacking? Clin Neuropsychol 35:206–218. https://doi.org/10.1080/13854046.2020.1801845
doi: 10.1080/13854046.2020.1801845
pubmed: 32749202
Dotson VM, Duarte A (2020) The importance of diversity in cognitive neuroscience. Ann N Y Acad Sci 1464:181–191. https://doi.org/10.1111/nyas.14268
doi: 10.1111/nyas.14268
pubmed: 31663150
Eastman MR, Ospina-Romero M, Westrick AC et al (2022) Does a cancer diagnosis in mid-to-later life modify racial disparities in memory aging? Alzheimer Dis Assoc Disord 36:140–147. https://doi.org/10.1097/WAD.0000000000000493
doi: 10.1097/WAD.0000000000000493
pubmed: 35125398
pmcid: 9132235
Ellis L, Canchola AJ, Spiegel D et al (2018) Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol 36:25–33. https://doi.org/10.1200/JCO.2017.74.2049
doi: 10.1200/JCO.2017.74.2049
pubmed: 29035642
Fitzpatrick TR, Edgar L, Holcroft C (2012) Assessing the relationship between physical fitness activities, cognitive health, and quality of life among older cancer survivors. J Psychosoc Oncol 30:556–572. https://doi.org/10.1080/07347332.2012.703768
doi: 10.1080/07347332.2012.703768
pubmed: 22963183
Flanagin A, Frey T, Christiansen SL, Committee AMAM of S (2021) Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 326:621–627. https://doi.org/10.1001/jama.2021.13304
doi: 10.1001/jama.2021.13304
pubmed: 34402850
Fowler ME, Wright NC, Triebel K et al (2022) The relationship between prior cancer diagnosis and all-cause dementia progression among US adults. J Alzheimer’s Dis 88:521–535. https://doi.org/10.3233/JAD-220054
doi: 10.3233/JAD-220054
Franco-Rocha OY, Mahaffey ML, Matsui W, Kesler SR (2023a) Remote assessment of cognitive dysfunction in hematologic malignancies using web-based neuropsychological testing. Cancer Med 12:6068–6076. https://doi.org/10.1002/cam4.5331
doi: 10.1002/cam4.5331
pubmed: 36221244
Franco-Rocha OY, Wheldon CW, Osier N et al (2023b) Cisheteronormativity and its influence on the psychosocial experience of LGBTQ+ people with cancer: a qualitative systematic review. Psychooncology 32:834–845. https://doi.org/10.1002/pon.6133
doi: 10.1002/pon.6133
pubmed: 37025048
Galantino ML, Greene L, Daniels L, Dooley B, Muscatello L, O'Donnell L (2012) Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Explore (NY) 8:127–135. https://doi.org/10.1016/j.explore.2011.12.001
Gavett BE, Fletcher E, Harvey D et al (2018) Ethnoracial differences in brain structure change and cognitive change. Neuropsychology 32:529–540. https://doi.org/10.1037/neu0000452
doi: 10.1037/neu0000452
pubmed: 29648842
pmcid: 6023745
Guerrero S, López-Cortés A, Indacochea A et al (2018) Analysis of racial/ethnic representation in select basic and applied cancer research studies. Sci Rep 8:13978. https://doi.org/10.1038/s41598-018-32264-x
doi: 10.1038/s41598-018-32264-x
pubmed: 30228363
pmcid: 6143551
Hardy SJ, Krull KR, Wefel JS, Janelsins M (2018) Cognitive changes in cancer survivors. Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meet 38:795–806. https://doi.org/10.1200/EDBK_201179
doi: 10.1200/EDBK_201179
Henneghan A, Stuifbergen A, Becker H et al (2018a) Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion. J Cancer Surviv 12:224–233. https://doi.org/10.1007/s11764-017-0661-9
doi: 10.1007/s11764-017-0661-9
pubmed: 29116555
Henneghan AM, Palesh O, Harrison M, Kesler SR (2018b) Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10 years post chemotherapy using machine learning. J Neuroimmunol 320:38–47. https://doi.org/10.1016/j.jneuroim.2018.04.012
doi: 10.1016/j.jneuroim.2018.04.012
pubmed: 29759139
pmcid: 6030687
Henneghan A, Haley AP, Kesler S (2020a) Exploring relationships among peripheral amyloid beta, tau, cytokines, cognitive function, and psychosomatic symptoms in breast cancer survivors. Biol Res Nurs 22:126–138. https://doi.org/10.1177/1099800419887230
doi: 10.1177/1099800419887230
pubmed: 31707784
Henneghan AM, Gibbons C, Harrison RA et al (2020b) Predicting patient reported outcomes of cognitive function using connectome-based predictive modeling in breast cancer. Brain Topogr 33:135–142. https://doi.org/10.1007/s10548-019-00746-4
doi: 10.1007/s10548-019-00746-4
pubmed: 31745689
Hess LM, Chambers SK, Hatch K et al (2010) Pilot study of the prospective identification of changes in cognitive function during chemotherapy treatment for advanced ovarian cancer. J Support Oncol 8:252–258. https://doi.org/10.1016/j.suponc.2010.09.028
doi: 10.1016/j.suponc.2010.09.028
pubmed: 21265392
Hshieh TT, Jung WF, Grande LJ et al (2018) Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncol 4:686–693. https://doi.org/10.1001/jamaoncol.2017.5674
doi: 10.1001/jamaoncol.2017.5674
pubmed: 29494732
pmcid: 5885202
Hughes A, Suleman S, Rimes KA et al (2020) Cancer-related fatigue and functional impairment—towards an understanding of cognitive and behavioural factors. J Psychosom Res. https://doi.org/10.1016/j.jpsychores.2020.110127
doi: 10.1016/j.jpsychores.2020.110127
pubmed: 33383523
Husain M, Nolan TS, Foy K et al (2019) An overview of the unique challenges facing African-American breast cancer survivors. Support Care Cancer 27:729–743. https://doi.org/10.1007/s00520-018-4545-y
doi: 10.1007/s00520-018-4545-y
pubmed: 30460398
Islami F, Miller KD, Siegel RL et al (2017) Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA Cancer J Clin 67:273–289. https://doi.org/10.3322/caac.21402
doi: 10.3322/caac.21402
pubmed: 28586094
Janelsins MC, Kohli S, Mohile SG et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38:431–438. https://doi.org/10.1053/j.seminoncol.2011.03.014
doi: 10.1053/j.seminoncol.2011.03.014
pubmed: 21600374
pmcid: 3120018
Janelsins MC, Mustian KM, Palesh OG et al (2012) Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer 20:831–839. https://doi.org/10.1007/s00520-011-1158-0
doi: 10.1007/s00520-011-1158-0
pubmed: 21533812
Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26:102–113. https://doi.org/10.3109/09540261.2013.864260
doi: 10.3109/09540261.2013.864260
pubmed: 24716504
pmcid: 4084673
Janelsins MC, Heckler CE, Peppone LJ et al (2017) Cognitive complaints in survivors of breast cancer after chemotherapy compared With Age-Matched Controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol 35:506–514 ((American Society of Clinical Oncology))
doi: 10.1200/JCO.2016.68.5826
pubmed: 28029304
Janelsins MC, Heckler CE, Peppone LJ et al (2018) Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study. J Clin Oncol 36:3231–3239. https://doi.org/10.1200/JCO
doi: 10.1200/JCO
pmcid: 6225503
Janelsins MC, Mohamed M, Peppone LJ et al (2022) Longitudinal changes in cognitive function in a nationwide cohort study of patients with lymphoma treated with chemotherapy. J Natl Cancer Inst 114:47–59. https://doi.org/10.1093/jnci/djab133
doi: 10.1093/jnci/djab133
pubmed: 34255086
Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA (2011) A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer 19:1647–1656. https://doi.org/10.1007/s00520-010-0997-4
doi: 10.1007/s00520-010-0997-4
pubmed: 20820813
Jean-Pierre P, Winters PC, Ahles TA et al (2012) Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. J Oncol Pract 8:30–34. https://doi.org/10.1200/JOP.2011.000231
doi: 10.1200/JOP.2011.000231
pubmed: 22548008
Jim HSL, Small BJ, Patterson S et al (2010) Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: a controlled comparison. Support Care Cancer 18:21–27. https://doi.org/10.1007/s00520-009-0625-3
doi: 10.1007/s00520-009-0625-3
pubmed: 19343369
Jim HSL, Phillips KM, Chait S et al (2012) Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol 30:3578–3587. https://doi.org/10.1200/JCO.2011.39.5640
doi: 10.1200/JCO.2011.39.5640
pubmed: 22927526
pmcid: 3462044
Jung MS, Cimprich B (2014) Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Cancer Nurs 37:31–42. https://doi.org/10.1097/NCC.0b013e3182980383
doi: 10.1097/NCC.0b013e3182980383
Kesler SR, Petersen ML, Rao V et al (2020) Functional connectome biotypes of chemotherapy-related cognitive impairment. J Cancer Surviv. https://doi.org/10.1007/s11764-020-00863-1
doi: 10.1007/s11764-020-00863-1
pubmed: 32157609
pmcid: 7958311
Kohler C, Chang M, Allemann-Su YY et al (2020) Changes in attentional function in patients from before through 12 months after breast cancer surgery. J Pain Symptom Manage 59:1172–1185. https://doi.org/10.1016/j.jpainsymman.2020.01.001
doi: 10.1016/j.jpainsymman.2020.01.001
pubmed: 31953207
pmcid: 7239765
Lange M, Joly F, Vardy J et al (2019) Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 30:1925–1940
doi: 10.1093/annonc/mdz410
pubmed: 31617564
Lawrence JA, Griffin L, Balcueva EP et al (2016) A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. J Cancer Surviv 10:176–184. https://doi.org/10.1007/s11764-015-0463-x
doi: 10.1007/s11764-015-0463-x
pubmed: 26130292
Lengacher CA, Reich RR, Kip KE et al (2015) Moderating effects of genetic polymorphisms on improvements in cognitive impairment in breast cancer survivors participating in a 6-week mindfulness-based stress reduction program. Biol Res Nurs 17:393–404. https://doi.org/10.1177/1099800415577633
doi: 10.1177/1099800415577633
pubmed: 25882604
Lewis KA, Brooks S, Carrasco R et al (2021) Best practices for recruitment of adolescents for biobanking and precision health research: a retrospective analysis comparing juvenile idiopathic arthritis cases with healthy controls. Pediatr Rheumatol 19:169. https://doi.org/10.1186/s12969-021-00652-9
doi: 10.1186/s12969-021-00652-9
Li J, Yu L, Long Z et al (2015) Perceived cognitive impairment in Chinese patients with breast cancer and its relationship with post-traumatic stress disorder symptoms and fatigue. Psychooncology 24:676–682. https://doi.org/10.1002/pon.3710
doi: 10.1002/pon.3710
pubmed: 25345397
Liang MI, Erich B, Bailey C et al (2019) Emerging from the haze: a pilot study evaluating feasibility of a psychoeducational intervention to improve cancer-related cognitive impairment in gynecologic cancer survivors. J Palliat Care 34:32–37. https://doi.org/10.1177/0825859718796794
doi: 10.1177/0825859718796794
pubmed: 30168368
Libert Y, Dubruille S, Borghgraef C et al (2016) Vulnerabilities in older patients when cancer treatment is initiated: does a cognitive impairment impact the two-year survival? PLoS ONE 11:e0159734. https://doi.org/10.1371/journal.pone.0159734
doi: 10.1371/journal.pone.0159734
pubmed: 27479248
pmcid: 4968794
Lou GM, Greene L, Daniels L et al (2012) Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Explor J Sci Heal 8:127–135. https://doi.org/10.1016/j.explore.2011.12.001
doi: 10.1016/j.explore.2011.12.001
Lozano-Ruiz A, Fasfous AF, Ibanez-Casas I et al (2021) Cultural bias in intelligence assessment using a culture-free test in Moroccan children. Arch Clin Neuropsychol off J Natl Acad Neuropsychol. https://doi.org/10.1093/arclin/acab005
doi: 10.1093/arclin/acab005
Lyon DE, Cohen R, Chen H et al (2016) Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer. J Neuroimmunol 301:74–82. https://doi.org/10.1016/j.jneuroim.2016.11.002
doi: 10.1016/j.jneuroim.2016.11.002
pubmed: 27890459
pmcid: 5181109
Mama SK, Li Y, Basen-Engquist K et al (2016) Psychosocial mechanisms linking the social environment to mental health in African Americans. PLoS ONE 11:e0154035. https://doi.org/10.1371/journal.pone.0154035
doi: 10.1371/journal.pone.0154035
pubmed: 27119366
pmcid: 4847864
Mandelblatt JS, Stern RA, Luta G et al (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: Is there an interaction between cancer and comorbidity? J Clin Oncol 32:1909–1918. https://doi.org/10.1200/JCO.2013.54.2050
doi: 10.1200/JCO.2013.54.2050
pubmed: 24841981
pmcid: 4050204
Mandelblatt JS, Small BJ, Luta G et al (2018) Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study. J Clin Oncol 36:3211–3222. https://doi.org/10.1200/JCO.18.00140
doi: 10.1200/JCO.18.00140
pmcid: 7237199
Manly JJ, Mungas D (2015) JGPS special series on race, ethnicity, life experiences, and cognitive aging. J Gerontol B Psychol Sci Soc Sci 70:509–511
doi: 10.1093/geronb/gbv030
pubmed: 25975291
Marín-Chollom AM, Hale C, Koch P et al (2022) Cognitive functioning and health in Hispanic/Latina breast cancer survivors. J Immigr Minor Heal 24:597–604. https://doi.org/10.1007/s10903-021-01300-w
doi: 10.1007/s10903-021-01300-w
Marson DC, Martin RC, Triebel KL, Nabors LB (2010) Capacity to consent to research participation in adults with malignant glioma. J Clin Oncol 28:3844–3850. https://doi.org/10.1200/JCO.2009.27.9091
doi: 10.1200/JCO.2009.27.9091
pubmed: 20644102
Melkonian SC, Jim MA, Haverkamp D et al (2019) Disparities in cancer incidence and trends among American Indians and Alaska Natives in the United States, 2010–2015. Cancer Epidemiol Biomarkers Prev 28:1604–1611. https://doi.org/10.1158/1055-9965.EPI-19-0288
doi: 10.1158/1055-9965.EPI-19-0288
pubmed: 31575554
pmcid: 6777852
Merriman JD, Aouizerat BE, Cataldo JK et al (2014) Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer. Cytokine 65:192–201. https://doi.org/10.1016/j.cyto.2013.11.003
doi: 10.1016/j.cyto.2013.11.003
pubmed: 24315345
Meyers CA, Geara F, Wong P-F, Morrison WH (2000) Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol 46:51–55
doi: 10.1016/S0360-3016(99)00376-4
Minas TZ, Kiely M, Ajao A, Ambs S (2021) An overview of cancer health disparities: new approaches and insights and why they matter. Carcinogenesis 42:2–13. https://doi.org/10.1093/carcin/bgaa121
doi: 10.1093/carcin/bgaa121
pubmed: 33185680
Moore KC, Stutzman S, Priddy L, Olson D (2019) Chemobrain: a pilot study exploring the severity and onset of chemotherapy-related cognitive impairment. Clin J Oncol Nurs 23:411–416. https://doi.org/10.1188/19.CJON.411-416
doi: 10.1188/19.CJON.411-416
pubmed: 31322622
Moreno-John G, Gachie A, Fleming CM et al (2004) Ethnic minority older adults participating in clinical research: developing trust. J Aging Health 16:93S-123S. https://doi.org/10.1177/0898264304268151
doi: 10.1177/0898264304268151
pubmed: 15448289
Morse L, Paul SM, Cooper BA et al (2023) Higher stress in oncology patients is associated with cognitive and evening physical fatigue severity. J Pain Symptom Manage 65:203–215. https://doi.org/10.1016/j.jpainsymman.2022.11.017
doi: 10.1016/j.jpainsymman.2022.11.017
pubmed: 36423801
Myers JS (2012) Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum 39:E31–E40. https://doi.org/10.1188/12.ONF.E31-E40
doi: 10.1188/12.ONF.E31-E40
pubmed: 22201666
Nakamura ZM, Deal AM, Nyrop KA et al (2019) Associations of functional, psychosocial, medical, and socio-demographic factors with cognitive screening in chemotherapy naïve patients with breast cancer. Psycho-Ongology 28:167–173. https://doi.org/10.1002/pon.4928
doi: 10.1002/pon.4928
National Cancer Institute (2020) Cancer disparities. https://www.cancer.gov/about-cancer/understanding/disparities . Accessed 28 Dec 2021
National Research Council (US) Panel (2004) Critical perspectives on racial and ethnic differences in health in late life. In: Anderson NB, Bulatao RA, Cohen B (eds) Race, ethnicity, and health in later life. National Academies Press (US), Washington, DC
Ng T, Teo SM, Yeo HL et al (2016) Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer. Neuro Oncol 18:244–251. https://doi.org/10.1093/neuonc/nov162
doi: 10.1093/neuonc/nov162
pubmed: 26289590
Oppegaard KR, Mayo SJ, Armstrong TS et al (2023) An evaluation of the multifactorial model of cancer-related cognitive impairment. Nurs Res 72:272–280. https://doi.org/10.1097/NNR.0000000000000660
doi: 10.1097/NNR.0000000000000660
pubmed: 37104681
Ottati A, Feuerstein M (2013) Brief self-report measure of work-related cognitive limitations in breast cancer survivors. J Cancer Surviv 7:262–273. https://doi.org/10.1007/s11764-013-0275-9
doi: 10.1007/s11764-013-0275-9
pubmed: 23552976
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4
doi: 10.1186/s13643-016-0384-4
pubmed: 27919275
pmcid: 5139140
Ozier EM, Taylor VJ, Murphy MC (2019) The cognitive effects of experiencing and observing subtle racial discrimination. J Soc Issues 75:1087–10115. https://doi.org/10.1111/josi.12349
doi: 10.1111/josi.12349
Paganini-Hill A, Clark LJ (2000) Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64:165–176. https://doi.org/10.1023/A:1006426132338
doi: 10.1023/A:1006426132338
pubmed: 11194452
Patel SK, Wong AL, Wong FL et al (2015) Inflammatory biomarkers, comorbidity, and neurocognition in women with newly diagnosed breast cancer. J Natl Cancer Inst 107:1–7. https://doi.org/10.1093/jnci/djv131
doi: 10.1093/jnci/djv131
Patel SK, Meier AM, Fernandez N et al (2017) Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer. Clin Neuropsychol 31:1375–1386. https://doi.org/10.1080/13854046.2016.1275819
doi: 10.1080/13854046.2016.1275819
pubmed: 28080264
pmcid: 5507751
Pendergrass JC, Targum SD, Harrison JE (2018) Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci 15:36–44
pubmed: 29497579
pmcid: 5819720
Piccirillo JF, Hardin FM, Nicklaus J et al (2015) Cognitive impairment after chemotherapy related to atypical network architecture for executive control. Oncol 88:360–368. https://doi.org/10.1159/000370117
doi: 10.1159/000370117
Raji MA, Tamborello LP, Kuo Y-F et al (2009) Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer. Med Oncol 26:452–459. https://doi.org/10.1007/s12032-008-9145-0
doi: 10.1007/s12032-008-9145-0
pubmed: 19067255
Rivera Mindt M, Byrd D, Saez P, Manly J (2010) Increasing culturally competent neuropsychological services for ethnic minority populations: a call to action. Clin Neuropsychol 24:429–453. https://doi.org/10.1080/13854040903058960
doi: 10.1080/13854040903058960
pubmed: 20373222
Robb C, Boulware D, Overcash J, Extermann M (2010) Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol 74:218–224. https://doi.org/10.1016/j.critrevonc.2009.07.002
doi: 10.1016/j.critrevonc.2009.07.002
pubmed: 19709899
Rodriguez-Wolfe M, Anglade D, Gattamorta KA et al (2019) Individualized piano instruction for improving cognition in breast cancer survivors. Oncol Nurs Forum 46:605–615. https://doi.org/10.1188/19.ONF.605-615
doi: 10.1188/19.ONF.605-615
pubmed: 31424459
Root JC, Zhou X, Ahn J et al (2022) Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study. Breast Cancer Res Treat 194:413–422. https://doi.org/10.1007/s10549-022-06623-2
doi: 10.1007/s10549-022-06623-2
pubmed: 35587324
pmcid: 9392482
Rust C, Davis C (2013) Chemobrain in underserved African American breast cancer survivors: a qualitative study. Clin J Oncol Nurs 17:E29–E34. https://doi.org/10.1188/13.CJON.E29-E34
doi: 10.1188/13.CJON.E29-E34
pubmed: 23538262
Seliktar N, Polek C, Brooks A, Hardie T (2015) Cognition in breast cancer survivors: hormones versus depression. Psychooncology 24:402–407. https://doi.org/10.1002/pon.3602
doi: 10.1002/pon.3602
pubmed: 25044780
Sharafeldin N, Richman J, Bosworth A et al (2020) Clinical and genetic risk prediction of cognitive impairment after blood or marrow transplantation for hematologic malignancy. J Clin Oncol 38:1312–1321. https://doi.org/10.1200/JCO.19.01085
doi: 10.1200/JCO.19.01085
pubmed: 32083992
pmcid: 8265387
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
doi: 10.3322/caac.21551
pubmed: 30620402
Stabellini N, Cullen J, Cao L et al (2023) Racial disparities in breast cancer treatment patterns and treatment related adverse events. Sci Rep 13:1233. https://doi.org/10.1038/s41598-023-27578-4
doi: 10.1038/s41598-023-27578-4
pubmed: 36683066
pmcid: 9868122
Statucka M, Cohn M (2019) Origins matter: culture impacts cognitive testing in Parkinson’s disease. Front Hum Neurosci 13:269. https://doi.org/10.3389/fnhum.2019.00269
doi: 10.3389/fnhum.2019.00269
pubmed: 31440150
pmcid: 6694800
Stern Y (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11:1006–1012. https://doi.org/10.1016/S1474-4422(12)70191-6
doi: 10.1016/S1474-4422(12)70191-6
pubmed: 23079557
pmcid: 3507991
Syed Alwi SM, Narayanan V, Mohd Taib NA, Che Din N (2021) Chemotherapy-related cognitive impairment (CRCI) among early-stage breast cancer survivors in Malaysia. J Clin Exp Neuropsychol 43:534–545. https://doi.org/10.1080/13803395.2021.1945539
doi: 10.1080/13803395.2021.1945539
pubmed: 34369307
Tan CJ, Mah JJJ, Goh WL et al (2020) Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers. Psychooncology 29:1355–1362. https://doi.org/10.1002/pon.5456
doi: 10.1002/pon.5456
pubmed: 32597001
pmcid: 7497100
Toh YL, Shariq Mujtaba J, Bansal S et al (2019) Prechemotherapy levels of plasma dehydroepiandrosterone and its sulfated form as predictors of cancer-related cognitive impairment in patients with breast cancer receiving chemotherapy. Pharmacotherapy 39:553–563. https://doi.org/10.1002/phar.2259
doi: 10.1002/phar.2259
pubmed: 30892712
pmcid: 6635742
Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473. https://doi.org/10.7326/M18-0850
doi: 10.7326/M18-0850
pubmed: 30178033
University of California San Francisco (2017) Recruitment of Underrepresented Study Populations. In: Clin. Transl. Sci. Inst. https://recruit.ucsf.edu/events/recruitment-underrepresented-study-populations#Several-speakers-talked-about-getting-results-back-to-the-community-What-are-some-creative-ideas-to-do-this--not-everyone-likes-lectures-talks . Accessed 29 Dec 2021
Van Arsdale A, Rosenbaum D, Kaur G et al (2016) Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies. Gynecol Oncol 141:323–328. https://doi.org/10.1016/j.ygyno.2016.03.001
doi: 10.1016/j.ygyno.2016.03.001
pubmed: 26946094
Von Ah D, Tallman EF (2015) Perceived cognitive function in breast cancer survivors: Evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy—cognitive function instrument. J Pain Symptom Manage 49:697–706. https://doi.org/10.1016/j.jpainsymman.2014.08.012
doi: 10.1016/j.jpainsymman.2014.08.012
Von Ah D, Crouch A, Arthur E et al (2023) Association between cardiovascular disease and cognitive dysfunction in breast cancer survivors. Cancer Nurs 46:E122–E128. https://doi.org/10.1097/NCC.0000000000001083
doi: 10.1097/NCC.0000000000001083
Wagner LI, Gray RJ, Sparano JA et al (2020) Patient-reported cognitive impairment among women with early breast cancer randomly assigned to endocrine therapy alone versus chemoendocrine therapy: results from TAILORx. J Clin Oncol 38:1875–1886. https://doi.org/10.1200/JCO.19.01866
doi: 10.1200/JCO.19.01866
pubmed: 32271671
pmcid: 7280048
Wefel JS, Kesler SR, Noll KR, Schagen SB (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65:123–138. https://doi.org/10.3322/caac.21258
doi: 10.3322/caac.21258
pubmed: 25483452
Williams DR, Priest N, Anderson NB (2016) Understanding associations among race, socioeconomic status, and health: Patterns and prospects. Heal Psychol off J Div Heal Psychol Am Psychol Assoc 35:407–411. https://doi.org/10.1037/hea0000242
doi: 10.1037/hea0000242
Williams AM, Shah R, Shayne M et al (2018) Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy. J Neuroimmunol 314:17–23. https://doi.org/10.1016/j.jneuroim.2017.10.005
doi: 10.1016/j.jneuroim.2017.10.005
pubmed: 29128118
Williams AM, van Wijngaarden E, Seplaki CL et al (2020) Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment. Leuk Lymphoma 61:1627–1635. https://doi.org/10.1080/10428194.2020.1728748
doi: 10.1080/10428194.2020.1728748
pubmed: 32148161
pmcid: 7384931
Yabroff KR, Reeder-Hayes K, Zhao J et al (2020) Health insurance coverage disruptions and cancer care and outcomes: systematic review of published research. J Natl Cancer Inst 112:671–687. https://doi.org/10.1093/jnci/djaa048
doi: 10.1093/jnci/djaa048
pubmed: 32337585
pmcid: 7357319
Yap NY, Tan NYT, Tan CJ et al (2020) Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer. Breast Cancer Res Treat 183:683–696. https://doi.org/10.1007/s10549-020-05807-y
doi: 10.1007/s10549-020-05807-y
pubmed: 32696315
Yee JY (2015) Whiteness and white supremacy. In: Wright JD (ed) International encyclopedia of the social & behavioral sciences, 2nd edn. Elsevier, Oxford, pp 569–574
doi: 10.1016/B978-0-08-097086-8.28099-9
Zahodne LB, Manly JJ, Narkhede A et al (2015) Structural MRI predictors of late-life cognition differ across African Americans, Hispanics, and Whites. Curr Alzheimer Res 12:632–639. https://doi.org/10.2174/1567205012666150530203214
doi: 10.2174/1567205012666150530203214
pubmed: 26027808
pmcid: 4872300
Zahodne LB, Manly JJ, Smith J et al (2017) Socioeconomic, health, and psychosocial mediators of racial disparities in cognition in early, middle, and late adulthood. Psychol Aging 32:118–130. https://doi.org/10.1037/pag0000154
doi: 10.1037/pag0000154
pubmed: 28287782
pmcid: 5369602
Zuelsdorff M, Okonkwo OC, Norton D et al (2020) Stressful life events and racial disparities in cognition among middle-aged and older adults. J Alzheimers Dis 73:671–682. https://doi.org/10.3233/JAD-190439
doi: 10.3233/JAD-190439
pubmed: 31815690
pmcid: 7481054